Announcements Trials
Browse Landscape

Phase

Phase 2 382Phase 1 129Phase 1/2 94Phase 3 88Phase EARLY_PHASE1 11Phase NA 8Phase 2/3 7Phase 4 5

Status

Unknown 2Completed 2Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 3Tumor-Agnostic 1CNS 1

Conditions

Unresectable Non-small Cell Lung Cancer (NSCLC) 1Neoplasms 1Meningeal Carcinomatosis 1Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Dexamethasone 56Metformin 50Cyclophosphamide 47Saline Solution 39Cytarabine 37Cisplatin 36Zoledronic Acid 34Letrozole 34Carboplatin 33Sodium Chloride 32Bupivacaine 31Docetaxel 30Bevacizumab 30Vincristine 29Methotrexate 29Fluorouracil 28Propofol 27Capecitabine 27Fentanyl 26Doxorubicin 26Rituximab 25Drug Therapy 25Dexmedetomidine 25Prednisone 23Paclitaxel 23Oxaliplatin 21Morphine 21Gemcitabine 21Radiotherapy 19Prednisolone 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × durvalumab × Clear all
NCT06031233 2026-03-30

MINUTE

Isala

Phase 4 Recruiting
776 enrolled
Tumor-Agnostic

Neoplasms

NCT04078152 2024-12-20

WAVE

AstraZeneca

Phase 4 Completed
163 enrolled 12 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04416633 2024-11-08

Study to Access Safety of Durvalumab in Indian Adult Patients With Locally Advanced NSCLC

AstraZeneca

Phase 4 Completed
100 enrolled 11 charts
Thoracic

Unresectable Non-small Cell Lung Cancer (NSCLC)

NCT04613284 2020-11-03

RELIEF

Shanghai Chest Hospital

Phase 4 Unknown
97 enrolled
Thoracic

Lung Neoplasms

NCT04356222 2020-05-27

Efficacy and Safety of Durvalumab in Non-Small Cell Lung Cancer With Leptomeningeal Metastasis

Hebei Medical University

Phase 4 Unknown
30 enrolled
CNS

Meningeal Carcinomatosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡